Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Growth Hormone as Add-on Treatment in Severe Fibromyalgia
NCT00497562Phase 2Completed
- Sponsor
- Centro Médico Teknon
- Start
- May 2004
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2 trial of somatropin in fibromyalgia (FM) (2 arms), sponsored by Centro Médico Teknon. Primary endpoint: Reduction in number of tender points at 1 year. Started May 2004; status: completed.
02
Drugs
somatropin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00497562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497562.